OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
3.060
-0.150 (-4.67%)
Mar 31, 2025, 4:00 PM EDT - Market closed
OncoCyte Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for OncoCyte stock have an average target of 4.56, with a low estimate of 4.00 and a high estimate of 5.00. The average target predicts an increase of 49.02% from the current stock price of 3.06.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OncoCyte stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +63.40% | Mar 28, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +30.72% | Mar 26, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +30.72% | Mar 25, 2025 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +38.89% | Mar 25, 2025 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +38.89% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
1.04M
from 1.88M
Decreased by -44.60%
Revenue Next Year
5.76M
from 1.04M
Increased by 452.50%
EPS This Year
-1.55
from -4.66
EPS Next Year
-1.37
from -1.55
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 1.5M | 7.8M |
| Avg | 1.0M | 5.8M |
| Low | 584,080 | 3.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | -21.9% | 645.7% |
| Avg | -44.6% | 452.5% |
| Low | -68.9% | 276.2% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -1.39 | -1.22 |
| Avg | -1.55 | -1.37 |
| Low | -1.85 | -1.52 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.